A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient

Bacteriophages are a promising therapeutic strategy among cystic fibrosis and lung-transplanted patients, considering the high frequency of colonization/infection caused by pandrug-resistant bacteria. However, little clinical data are available regarding the use of phages for infections with Achromo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebeaux, David, Merabishvili, Maia, Caudron, Eric, Lannoy, Damien, Van Simaey, Leen, Duyvejonck, Hans, Guillemain, Romain, Thumerelle, Caroline, Podglajen, Isabelle, Compain, Fabrice, Kassis, Najiby, Mainardi, Jean-Luc, Wittmann, Johannes, Rohde, Christine, Pirnay, Jean-Paul, Dufour, Nicolas, Vermeulen, Stefan, Gansemans, Yannick, Van Nieuwerburgh, Filip, Vaneechoutte, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824836/
https://www.ncbi.nlm.nih.gov/pubmed/33466377
http://dx.doi.org/10.3390/v13010060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824836/
https://www.ncbi.nlm.nih.gov/pubmed/33466377
http://dx.doi.org/10.3390/v13010060

Ejemplares similares